查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088840

非鴉片類鎮痛貼市場：按貼片類型、技術、應用、最終用戶和分銷管道分類－2026-2032年全球市場預測

Non-opioid Pain Patches Market by Patch Type, Technology, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，非鴉片類止痛貼市場將成長至 21.4046 億美元，複合年成長率為 13.22%。

主要市場統計數據
基準年 2025 8.9706億美元
預計年份：2026年 1,024,290,000 美元
預測年份 2032 21.4046億美元
複合年成長率 (%) 13.22%

隨著臨床醫生、保險公司和消費者越來越重視局部鎮痛（與許多口服藥物相比，局部鎮痛的全身暴露量更低），非鴉片類鎮痛貼劑正從局部治療的小眾類別轉變為疼痛管理的重要戰略領域。此類別包括處方箋Lidocaine貼片、辣椒素製劑、部分地區核准的局部非類固醇抗發炎藥貼劑，以及含有薄荷醇、水楊酸甲酯和辣椒素等成分的非處方產品。

市場需求主要源自於全球肌肉骨骼疾病、神經病變疼痛、運動傷害、關節炎相關疼痛和背痛等疾病帶來的沉重負擔，以及公共衛生部門為減少不必要的鴉片類藥物濫用而採取的措施。美國FDA、符合EMA標準的歐洲法律規範機構以及各國藥品監管機構持續對產品功效聲明、安全性聲明、生產品質和市場准入要求進行監管。對於行業相關人員，推動市場成長的關鍵因素包括循證療效、良好的皮膚耐受性、粘附性、穩定的藥物釋放以及與處方藥和消費者自我護理產品的明顯區別。

正在重塑止痛貼市場的變革性變化

受多種因素推動，非鴉片類鎮痛貼片市場正在經歷一場變革：鴉片類藥物的合理使用、自我護理意識的提高、人口老化以及經皮吸收技術的進步。臨床指引日益建議多管齊下的疼痛管理方案，尤其強調局部用藥，用於緩解局部疼痛或患者因擔心某些口服藥物可能引起的胃腸道、肝臟或全身不利事件而尋求其他治療選擇的情況。

人工智慧對非鴉片類鎮痛貼的累積影響

人工智慧正透過改進配方設計、臨床證據產生、供應計畫和安全性監測，開始影響非鴉片類鎮痛貼片的價值鏈。利用機器學習可以篩檢輔料組合、模擬皮膚滲透性、預測濕度和運動條件下的黏附行為，並針對特定解剖部位最佳化貼片形狀。

亞太地區、北美地區、拉丁美洲地區、歐洲地區以及中東和非洲地區的關鍵區域洞察

亞太地區非鴉片類鎮痛貼片市場潛力巨大，這得益於其龐大的患者群體、不斷完善的醫療保健服務、快速擴張的藥房零售網路，以及中國、印度、日本、韓國和澳洲等國家強大的生產生態系統。此外，該地區人口老化、活躍消費者以及需要應對肌肉骨骼疼痛的患者對便捷的局部鎮痛貼片的需求日益成長。北美地區仍然是循證局部鎮痛藥的主要市場，這得益於鴉片類藥物減量計劃、非處方藥零售市場的高滲透率、運動醫學領域的活躍需求，以及處方藥和非處方藥完善的監管流程。

東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約市場的關鍵群體分析

由於可支配收入的成長、藥局現代化、醫療旅遊以及區域間監管協調的努力，局部鎮痛藥的可及性不斷提高，東協市場的重要性日益凸顯。海灣合作理事會（GCC）地區受益於高額的醫療保健支出、私立醫院的擴張以及對品牌自我護理產品接受度高的消費者群體，但對進口的依賴、清真認證方面的考慮以及監管註冊週期等問題仍然是商業化過程中面臨的重大挑戰。

深入分析主要非鴉片類止痛貼片市場的關鍵國家。

美國的特點是鴉片類藥物管控嚴格、零售藥局通路發達、在運動醫學廣泛應用，以及美國食品藥物管理局（FDA）對非處方和處方箋鎮痛藥的監管。而加拿大則在公共衛生領域對鴉片類藥物持謹慎態度，同時擁有穩定的藥局分銷網路、省級藥品准入政策以及雙語標籤要求。墨西哥和巴西是拉丁美洲的重要市場，在這些地區，價格實惠、品牌學名藥、連鎖藥局和零售通路的普及推動了非鴉片類鎮痛貼片在治療背痛、關節炎疼痛和輕微肌肉骨骼損傷方面的流行。

為行業領導者提供的實用建議

產業領導者應優先考慮經臨床驗證的產品差異化，包括檢驗的配戴時間、可預測的藥物釋放、低刺激性、強黏附性以及針對每種適應症的清晰療效標籤。投資於真實世界數據、人體工學測試、穩定性數據、皮膚安全性評估以及患者依從性研究的公司，能夠加強與臨床醫生、零售商、監管機構和消費者的關係。

調查方法

本執行摘要採用結構化的二手調查方法編寫，並符合市場情報最佳實踐。輸入資訊包括公開的監管指南、藥品標籤框架、臨床指南趨勢、藥物安全監測原則、醫療保健可近性指標、人口統計模式、疼痛管理文獻以及自我護理和鴉片類藥物合理管理方面已證實的改進。

結論

隨著醫療保健系統尋求切實可行的替代方案來緩解局部疼痛、提高患者便利性並降低鴉片類藥物相關風險，非鴉片類鎮痛貼片有望在現代疼痛管理中發揮更大的作用。該市場最大的機會將來自於臨床證據、監管合規性、製劑性能、患者舒適度和便捷的分銷網路這四者的交匯點。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 非鴉片類鎮痛貼片市場：依貼片類型分類

  • Lidocaine貼劑
  • 雙氯芬酸鈉貼劑
  • 辣椒素貼片
  • 水楊酸甲酯貼片
  • 酮洛芬貼劑
  • 薄荷醇貼片

第8章 非鴉片類鎮痛貼片市場：依技術分類

  • 矩陣型補丁
  • 水庫型斑塊
  • 含藥黏性貼劑
  • 微針加強貼片

第9章 非鴉片類鎮痛貼片市場：依應用領域分類

  • 急性疼痛
    • 術後疼痛
    • 運動傷害引起的疼痛
  • 慢性疼痛
    • 關節炎
    • 神經病變疼痛

第10章 非鴉片類鎮痛貼市場：依最終用戶分類

  • 診所
  • 居家照護
  • 醫院
    • 私立醫院
    • 公立醫院

第11章 非鴉片類鎮痛貼市場：依通路分類

  • 線上
  • 離線

第12章 非鴉片類鎮痛貼市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 非鴉片類鎮痛貼片市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 非鴉片類鎮痛貼市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • AdhexPharma SAS
  • Altergon Italia Srl
  • Amneal Pharmaceuticals, Inc.
  • Bayer AG
  • Beiersdorf AG
  • Cipla Limited
  • Endo International plc
  • GlaxoSmithKline plc
  • Grunenthal GmbH
  • Hisamitsu Pharmaceutical Co., Inc.
  • IBSA Institut Biochimique SA
  • Johnson & Johnson Services, Inc.
  • Mentholatum Company, Inc.
  • Novartis AG
  • Perrigo Company plc
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Limited
  • Teikoku Seiyaku Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.
  • Zydus Lifesciences Limited
Product Code: MRR-AD36CD897D7B

The Non-opioid Pain Patches Market is projected to grow by USD 2,140.46 million at a CAGR of 13.22% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 897.06 million
Estimated Year [2026] USD 1,024.29 million
Forecast Year [2032] USD 2,140.46 million
CAGR (%) 13.22%

Non-opioid pain patches are moving from a niche topical therapy category into a strategic pain-management segment as clinicians, payers, and consumers prioritize localized analgesia with lower systemic exposure than many oral medicines. The category spans prescription lidocaine patches, capsaicin systems, topical NSAID patches where approved, and over-the-counter counterirritant products using ingredients such as menthol, methyl salicylate, and capsaicin.

Demand is supported by the documented global burden of musculoskeletal disorders, neuropathic pain, sports injuries, arthritis-related pain, and back pain, alongside public-health efforts to reduce unnecessary opioid exposure. Regulatory oversight by agencies such as the U.S. FDA, EMA-aligned European authorities, and national drug regulators continues to shape product claims, safety labeling, manufacturing quality, and market access. For industry participants, growth depends on evidence-backed efficacy, skin tolerability, adhesive performance, drug-release consistency, and clear differentiation between prescription therapeutics and consumer self-care products.

Transformative Shifts Reshaping the Pain Patch Landscape

The non-opioid pain patches landscape is being reshaped by the convergence of opioid stewardship, self-care adoption, aging populations, and advances in transdermal delivery. Clinical guidelines increasingly favor multimodal pain management, and topical therapies are valued when pain is localized and patients seek options that may reduce gastrointestinal, hepatic, or systemic adverse-event concerns associated with some oral therapies.

Manufacturers are also competing on formulation science rather than ingredient familiarity alone. Improvements in pressure-sensitive adhesives, permeation enhancers, hydrogel matrices, and controlled-release designs are helping brands address wear time, residue, odor, heat sensitivity, and patient comfort. Retail pharmacy, e-commerce, and telehealth-enabled care pathways are expanding access, while regulators continue to scrutinize drug-device combination characteristics, labeling substantiation, pharmacovigilance, and quality systems.

Cumulative Impact of Artificial Intelligence on Non-Opioid Pain Patches

Artificial intelligence is beginning to influence the non-opioid pain patches value chain by improving formulation design, clinical evidence generation, supply planning, and safety monitoring. Machine learning can help screen excipient combinations, model skin permeation, predict adhesive behavior under humidity and movement, and optimize patch geometry for specific anatomical sites.

AI-enabled analytics also support pharmacovigilance by detecting adverse-event signals related to skin irritation, allergic reactions, misuse, heat exposure, or off-label application patterns across structured and unstructured data sources. In commercial operations, predictive models can improve inventory planning across retail and hospital channels, identify unmet needs among chronic pain populations, and support personalized education. The cumulative impact is not a replacement for clinical validation; rather, AI can shorten iteration cycles and strengthen data-backed decisions when governed by transparent, compliant quality frameworks.

Key Regional Insights Across Asia-Pacific, North America, Latin America, Europe, Middle East, and Africa

Asia-Pacific is a high-potential region for non-opioid pain patches due to large patient populations, rising healthcare access, rapid pharmacy retail expansion, and strong manufacturing ecosystems in countries such as China, India, Japan, South Korea, and Australia. The region also reflects increasing demand for convenient topical analgesic patches among aging populations, active consumers, and patients managing musculoskeletal pain. North America remains a leading environment for evidence-based topical analgesics, supported by opioid-reduction initiatives, strong OTC retail penetration, active sports medicine demand, and established regulatory pathways for prescription and nonprescription products.

Latin America shows growing uptake as urban pharmacies, private healthcare networks, and consumer self-care trends expand, with Brazil and Mexico acting as important demand centers for affordable and branded topical pain relief. Europe benefits from mature reimbursement discussions, aging demographics, and strict safety, labeling, and pharmacovigilance expectations under national and EU-aligned frameworks. The Middle East is gaining traction through modernizing healthcare infrastructure, high private-sector participation in GCC markets, and demand for convenient pain-relief formats, while Africa remains an emerging opportunity shaped by affordability, distribution reach, healthcare access gaps, and the need for trusted OTC products in fragmented retail environments.

Key Group Insights for ASEAN, GCC, EU, BRICS, G7, and NATO Markets

ASEAN markets are becoming increasingly relevant as rising disposable income, pharmacy modernization, medical tourism, and regional harmonization efforts support broader access to topical pain relief. The GCC benefits from high healthcare spending, expanding private hospitals, and a consumer base receptive to branded self-care products, although import dependence, halal considerations, and regulatory registration timelines remain important commercialization factors.

The European Union emphasizes quality, pharmacovigilance, ingredient substantiation, sustainability, and product-safety documentation, creating opportunities for compliant and clinically differentiated non-opioid pain patches. BRICS economies combine large patient pools with growing domestic manufacturing capabilities, expanding pharmacy networks, and price-sensitive access models. G7 markets generally lead in regulatory maturity, premium product positioning, clinical evidence requirements, and post-market safety expectations, while NATO-linked markets overlap with many advanced healthcare systems where defense readiness, workforce rehabilitation, sports medicine, and musculoskeletal care reinforce demand for non-opioid pain-management options.

Key Country Insights Covering Major Non-Opioid Pain Patch Markets

The United States is defined by opioid stewardship, strong retail pharmacy channels, sports medicine utilization, and FDA oversight for OTC and prescription topical analgesics, while Canada combines public-health caution on opioids with stable pharmacy distribution, provincial access considerations, and bilingual labeling requirements. Mexico and Brazil are important Latin American markets where affordability, branded generics, pharmacy chains, and retail access influence adoption of non-opioid pain patches for back pain, arthritis-related pain, and minor musculoskeletal injuries.

In Europe, the United Kingdom, Germany, France, Italy, and Spain show demand linked to aging populations, sports injuries, arthritis, occupational strain, and chronic back pain, with national reimbursement, pharmacy classification, and advertising rules shaping uptake; Russia remains a distinct market influenced by local registration, supply-chain resilience, domestic sourcing priorities, and price sensitivity. In Asia-Pacific, China and India offer scale, manufacturing advantages, and expanding consumer healthcare channels; Japan has a sophisticated transdermal and aging-care environment; South Korea supports innovation through advanced healthcare infrastructure and high digital-health adoption; and Australia combines strong OTC governance with demand for active-lifestyle pain relief and pharmacist-guided self-care.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically supported product differentiation, including validated wear time, predictable drug release, low irritation potential, strong adhesion, and clear indication-specific claims. Companies that invest in real-world evidence, human factors testing, stability data, dermatologic safety evaluation, and patient adherence insights can strengthen trust with clinicians, retailers, regulators, and consumers.

Commercial teams should segment the market by pain type, channel, ingredient class, and regulatory status rather than treating all patches as interchangeable. Strategic actions include building pharmacy education programs, improving e-commerce content compliance, partnering with sports medicine and rehabilitation providers, diversifying supply sources for adhesives and active ingredients, and using AI-driven planning to reduce stockouts. Sustainability should also be integrated through responsible packaging, solvent management, waste reduction, and quality-by-design manufacturing practices.

Research Methodology

This executive summary is developed using a structured secondary-research methodology aligned with market-intelligence best practices. Inputs include publicly available regulatory guidance, drug labeling frameworks, clinical guideline trends, pharmacovigilance principles, healthcare access indicators, demographic patterns, pain-management literature, and documented shifts in self-care and opioid stewardship.

The analysis triangulates insights across product type, active ingredient class, distribution channel, regional regulation, and end-user behavior. Emphasis is placed on verified, data-backed themes rather than unsupported market-size, market-share, or forecasting claims.

Conclusion

Non-opioid pain patches are positioned to play a larger role in modern pain management as healthcare systems seek practical alternatives that support localized relief, patient convenience, and opioid-risk reduction. The market's strongest opportunities will emerge where clinical evidence, regulatory compliance, formulation performance, patient comfort, and accessible distribution intersect.

Companies that combine robust science with patient-centered design, AI-enabled operations, and region-specific commercialization strategies will be best placed to compete. As adoption expands across mature and emerging markets, the winners will be those that demonstrate safety, efficacy, affordability, labeling integrity, and trust across the full product life cycle.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Non-opioid Pain Patches Market, by Patch Type

  • 7.1. Lidocaine Patches
  • 7.2. Diclofenac Patches
  • 7.3. Capsaicin Patches
  • 7.4. Methyl Salicylate Patches
  • 7.5. Ketoprofen Patches
  • 7.6. Menthol Patches

8. Non-opioid Pain Patches Market, by Technology

  • 8.1. Matrix Patches
  • 8.2. Reservoir Patches
  • 8.3. Drug-in-Adhesive Patches
  • 8.4. Microneedle-Enhanced Patches

9. Non-opioid Pain Patches Market, by Application

  • 9.1. Acute Pain
    • 9.1.1. Postoperative Pain
    • 9.1.2. Sports Injury Pain
  • 9.2. Chronic Pain
    • 9.2.1. Arthritis
    • 9.2.2. Neuropathic Pain

10. Non-opioid Pain Patches Market, by End User

  • 10.1. Clinics
  • 10.2. Home Care
  • 10.3. Hospitals
    • 10.3.1. Private Hospitals
    • 10.3.2. Public Hospitals

11. Non-opioid Pain Patches Market, by Distribution Channel

  • 11.1. Online
  • 11.2. Offline

12. Non-opioid Pain Patches Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Non-opioid Pain Patches Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Non-opioid Pain Patches Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. AdhexPharma SAS
  • 16.2. Altergon Italia S.r.l.
  • 16.3. Amneal Pharmaceuticals, Inc.
  • 16.4. Bayer AG
  • 16.5. Beiersdorf AG
  • 16.6. Cipla Limited
  • 16.7. Endo International plc
  • 16.8. GlaxoSmithKline plc
  • 16.9. Grunenthal GmbH
  • 16.10. Hisamitsu Pharmaceutical Co., Inc.
  • 16.11. IBSA Institut Biochimique SA
  • 16.12. Johnson & Johnson Services, Inc.
  • 16.13. Mentholatum Company, Inc.
  • 16.14. Novartis AG
  • 16.15. Perrigo Company plc
  • 16.16. Pfizer Inc.
  • 16.17. Sanofi
  • 16.18. Sun Pharmaceutical Industries Limited
  • 16.19. Teikoku Seiyaku Co., Ltd.
  • 16.20. Teva Pharmaceutical Industries Ltd.
  • 16.21. Viatris Inc.
  • 16.22. Zhejiang Hisun Pharmaceutical Co., Ltd.
  • 16.23. Zydus Lifesciences Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL NON-OPIOID PAIN PATCHES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL NON-OPIOID PAIN PATCHES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL NON-OPIOID PAIN PATCHES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL NON-OPIOID PAIN PATCHES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL NON-OPIOID PAIN PATCHES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL NON-OPIOID PAIN PATCHES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LIDOCAINE PATCHES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL LIDOCAINE PATCHES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL LIDOCAINE PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DICLOFENAC PATCHES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DICLOFENAC PATCHES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DICLOFENAC PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CAPSAICIN PATCHES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CAPSAICIN PATCHES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CAPSAICIN PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL METHYL SALICYLATE PATCHES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL METHYL SALICYLATE PATCHES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL METHYL SALICYLATE PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL KETOPROFEN PATCHES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL KETOPROFEN PATCHES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL KETOPROFEN PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MENTHOL PATCHES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MENTHOL PATCHES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MENTHOL PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MATRIX PATCHES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MATRIX PATCHES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MATRIX PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RESERVOIR PATCHES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RESERVOIR PATCHES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RESERVOIR PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DRUG-IN-ADHESIVE PATCHES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DRUG-IN-ADHESIVE PATCHES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DRUG-IN-ADHESIVE PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MICRONEEDLE-ENHANCED PATCHES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MICRONEEDLE-ENHANCED PATCHES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MICRONEEDLE-ENHANCED PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ACUTE PAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ACUTE PAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ACUTE PAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL POSTOPERATIVE PAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL POSTOPERATIVE PAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL POSTOPERATIVE PAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SPORTS INJURY PAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SPORTS INJURY PAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SPORTS INJURY PAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CHRONIC PAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CHRONIC PAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CHRONIC PAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ARTHRITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ARTHRITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NEUROPATHIC PAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEUROPATHIC PAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NEUROPATHIC PAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. GCC NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 142. GCC NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. GCC NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. GCC NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. GCC NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 146. GCC NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 147. GCC NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. GCC NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 149. GCC NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. G7 NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 169. G7 NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. G7 NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. G7 NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. G7 NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 173. G7 NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 174. G7 NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. G7 NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 176. G7 NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. NATO NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 178. NATO NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. NATO NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. NATO NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. NATO NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 182. NATO NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 183. NATO NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. NATO NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 185. NATO NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL NON-OPIOID PAIN PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 201. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 202. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 204. CANADA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 205. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 210. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 211. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 213. MEXICO NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 219. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 220. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 222. BRAZIL NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED KINGDOM NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 232. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 235. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 237. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 238. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 240. GERMANY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 241. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 242. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 244. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 246. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 247. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 249. FRANCE NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 250. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 251. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 253. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 255. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 256. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 258. RUSSIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 259. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 260. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 262. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 264. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 265. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 267. ITALY NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 268. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 271. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 272. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 273. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 274. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 276. SPAIN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 286. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 289. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 290. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 291. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 292. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 293. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 294. INDIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 295. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 296. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 298. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 299. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 300. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 301. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 302. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 303. JAPAN NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 304. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 305. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 307. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 308. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 309. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 310. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 311. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 312. AUSTRALIA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 313. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 314. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY PATCH TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 316. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 317. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY ACUTE PAIN, 2018-2032 (USD MILLION)
  • TABLE 318. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
  • TABLE 319. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 320. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 321. SOUTH KOREA NON-OPIOID PAIN PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)